Biotech & Pharmaceuticals

Ferrer

Here at Ferrer, we want to promote a new way of doing business and a new way of being in the world. We want to make a positive impact in society. Our business is not an end in itself, but a means to generate substantial social change. We work to achieve a minimum level of […]

Ferrer Read More »

American Specialty Health – ASH

American Specialty Health Incorporated (ASH) is one of the nation’s premier independent and privately-owned specialty health organizations offering technology-enabled benefits management services, including musculoskeletal health provider networks and programs, fitness center networks and exercise programs, and health management solutions for health plans, insurance carriers, employers and others. With offices in Carmel (Indianapolis), IN, San Diego,

American Specialty Health – ASH Read More »

Iasis Healthcare

IASIS Healthcare, located in Franklin, Tennessee, was the for-profit owner and operator of medium-sized acute care hospitals in high-growth urban and suburban markets. IASIS owns or leases 17 acute care hospital facilities and one behavioral health hospital facility with a total of 3,581 licensed beds and has total annual net revenue of approximately $3.2 billion.

Iasis Healthcare Read More »

Cytel

At Cytel we believe the clinical development of safe and effective medicines is crucial for human welfare. We believe that if you don’t get the trial design right, nothing else matters; and that every sponsor should evaluate the option of an adaptive approach. While Cytel may be best known for our pioneering work in adaptive

Cytel Read More »

Chroma Technology Corp

Founded in 1991 as a 100% employee-owned company, Chroma Technology is a leading manufacturer and OEM supplier of highly precise optical filters using thin-film coating technology. Our reputation is built on our dedicated customer service, including free technical and application support. We remain committed to serving the scientific and technical communities in their pursuit of

Chroma Technology Corp Read More »

Costello Medical Consulting

Due to the demand across an increasing range of service offerings and geographies, Costello Medical has grown organically since our foundation in 2008 to become one of the most established independent agencies delivering medical communications and health economic services. Our teams are led by talented individuals who started and have built their careers at Costello

Costello Medical Consulting Read More »

Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company’s in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type

Intellia Therapeutics, Inc. Read More »

Chiesi Group

Chiesi is an international, research-focused biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. By changing its legal status to a Benefit Corporation in Italy, the US,

Chiesi Group Read More »

Primary.Health

Primary Health Care (PHC) has been providing medical and dental care to underserved individuals and families living in Des Moines since 1981. Today, we provide care and services in Ames, Marshalltown and Des Moines. PHC has three dental clinics, seven medical clinics and four satellite clinics across these communities. PHC also operates a mobile health

Primary.Health Read More »

Halozyme Therapeutics, Inc.

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company’s products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as

Halozyme Therapeutics, Inc. Read More »

Scroll to Top